Respiratory Health and Sleep Apnea Flashcards

A CMV driver with severe OSA (baseline AHI 52) underwent uvulopalatopharyngoplasty (UPPP) 8 months ago. He discontinued CPAP post-surgery, believing the procedure cured him. No post-operative sleep study has been performed. He presents for medical certification. What is the most appropriate action?

Answer: Disqualify until post-operative polysomnography confirms adequate OSA resolution

Surgical treatment for OSA does not guarantee cure. UPPP has an AHI normalization success rate of approximately 40–50%, and outcomes can change over time. Without objective post-operative polysomnography, the medical examiner cannot confirm OSA is adequately controlled. A 90-day conditional certificate is inappropriate because no objective data exists yet — the driver must first provide documentation of treatment efficacy, not the other way around.

A CMV driver's auto-titrating PAP (APAP) device download for the past 90 days shows: average nightly use 5.1 hours, residual AHI 4.3, and 'large leak' flagged on 34 of 90 nights. The driver's ESS is 7 and he reports no symptoms. What is the most critical concern the medical examiner must address before making a certification decision?

Answer: Significant large-leak nights may invalidate the residual AHI data, potentially masking true OSA severity

Large mask leaks corrupt the APAP's flow-signal processing, causing the device to misclassify respiratory events and systematically underestimate the true residual AHI. When 38% of nights (34/90) have significant leaks, the reported AHI of 4.3 is unreliable and cannot be used to confirm treatment adequacy. The examiner should require leak resolution — mask refitting, alternate interface, or chin strap — followed by a new 90-day monitoring period with clean data before making a certification determination.

A CMV driver with severe OSA (baseline AHI 56) has 4 months of CPAP therapy. His download shows: mean nightly use 5.9 hours, residual AHI 3.1, but his sleep physician reports three episodes of unintentional napping off-duty. ESS is 9 (down from 16 at diagnosis). What additional evaluation is most appropriate before certification?

Answer: Maintenance of Wakefulness Test (MWT) to assess ability to sustain wakefulness in a sedentary setting

The MWT is the most operationally relevant test for CMV fitness evaluation. Unlike the MSLT — which measures how quickly someone falls asleep — the MWT assesses the ability to remain awake during quiet, monotonous conditions, directly mirroring the demands of long-haul driving. With a history of unintentional napping despite adequate CPAP adherence, objective wakefulness testing is indicated. The MWT is the recognized gold standard when residual excessive daytime sleepiness is suspected despite documented treatment compliance.

A 61-year-old CMV driver undergoes polysomnography revealing an AHI of 44, with 80% of events in a crescendo-decrescendo airflow pattern consistent with Cheyne-Stokes respirations. He has no cardiac history, but an ordered echocardiogram shows an ejection fraction of 38%. Which statement best characterizes his certification status?

Answer: Both the underlying cardiac dysfunction and the sleep-disordered breathing must be adequately treated and documented before certification is considered

Cheyne-Stokes respirations with reduced ejection fraction indicate central sleep apnea secondary to heart failure (CSA-CSB), not primary obstructive sleep apnea. Standard CPAP is generally ineffective for this pattern, and adaptive servo-ventilation (ASV) is contraindicated in reduced-EF heart failure per current guidelines. The ejection fraction of 38% itself represents significant systolic dysfunction warranting cardiovascular evaluation. Neither condition alone defines the outcome — both the cardiac dysfunction and the sleep-disordered breathing must be optimally managed with documented specialist clearance before certification is appropriate.

A CMV driver was diagnosed with moderate OSA (AHI 22) 3 years ago and has since lost 68 pounds (BMI dropped from 38 to 27). He has been symptom-free for 6 months and requests that CPAP monitoring requirements be discontinued. What is the appropriate response?

Answer: Require a repeat diagnostic polysomnography off CPAP before modifying any treatment requirements

Significant weight loss can reduce or eliminate OSA, but this must be confirmed with objective testing — not inferred from symptoms or BMI change alone. OSA is frequently asymptomatic, and a driver who feels fine may still have clinically significant residual events during sleep. A formal repeat polysomnography performed off CPAP is required to document whether OSA has genuinely resolved before treatment requirements can be modified. Assuming resolution without testing creates an unacceptable safety gap. Conversely, maintaining prior requirements permanently without allowing reassessment is unnecessarily rigid.

A driver suffered acute hypercapnic respiratory failure requiring intubation 5 months ago and was subsequently diagnosed with obesity hypoventilation syndrome (OHS). He now uses BiPAP (IPAP 20 / EPAP 8). Current data: daytime ABG on room air shows PaO2 72 mmHg, PaCO2 44 mmHg; sleep study on BiPAP shows residual AHI 2.8, nadir SpO2 91%. What is the most accurate certification determination?

Answer: Possible certification requires pulmonologist clearance confirming OHS stability and that all FMCSA respiratory thresholds are met

OHS with a prior acute decompensation requiring intubation is a serious condition, but it is not a categorical permanent disqualifier if optimally managed and stable. However, a daytime PaO2 of 72 mmHg is borderline hypoxemia, and the history of acute respiratory failure demands specialist oversight — the medical examiner alone cannot adequately assess this complexity. A pulmonologist must confirm stability, the adequacy of current BiPAP settings, and that the driver meets FMCSA functional respiratory thresholds. Certifying without specialist clearance is premature; categorically disqualifying without allowing for specialist evaluation is overly rigid and not supported by FMCSA guidance.